Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

OA09.06 Molecular Alterations and Estimated Indoor Radon in NSCLC Patients From the French National Cancer Institute Registry: Radon France Study

Journal of Thoracic Oncology

English

P1.01-18 Immunosenescence Correlates With Progression Upon PD-(L)-1 Blockade (IO) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients

Journal of Thoracic Oncology

English

P2.04-27 Ph II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC

Journal of Thoracic Oncology

English

A Positive Feedback Loop Involving the WNT/Β-Catenin/Myc/Sox2 Axis Defines a Highly Tumorigenic Cell Subpopulation in ALK-positive Anaplastic Large Cell Lymphoma

Journal of Hematology and Oncology

English

An Uncommon Insertion Mutation in Exon 19 of EGFR Showed Stable Disease After TKI Treatment

Journal of Thoracic Oncology

English

P1.04-11 Exploring the Germ-Line Contribution to Exceptional Response to PD-1/PD-L1 Inhibition in Patients With NSCLC by Whole Genome Sequencing

Journal of Thoracic Oncology

English

Fatal Airway Inflammation Induced by Pembrolizumab in a Patient With NSCLC

Journal of Thoracic Oncology

English

Loss of P16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated With Worse Outcome and Younger Age in Thymic Carcinomas

Journal of Thoracic Oncology

English

Sequential Atezolizumab Achieved Remarkable Efficacy After Local Radiotherapy in a Patient With Lung Adenocarcinoma Refractory to Nivolumab

Journal of Thoracic Oncology

English

Adi Gazdar, MD: Physician, Pathologist, Scholar, Collaborator, Friend

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

OA09.06 Molecular Alterations and Estimated Indoor Radon in NSCLC Patients From the French National Cancer Institute Registry: Radon France Study

P1.01-18 Immunosenescence Correlates With Progression Upon PD-(L)-1 Blockade (IO) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients

P2.04-27 Ph II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC

A Positive Feedback Loop Involving the WNT/Β-Catenin/Myc/Sox2 Axis Defines a Highly Tumorigenic Cell Subpopulation in ALK-positive Anaplastic Large Cell Lymphoma

An Uncommon Insertion Mutation in Exon 19 of EGFR Showed Stable Disease After TKI Treatment

P1.04-11 Exploring the Germ-Line Contribution to Exceptional Response to PD-1/PD-L1 Inhibition in Patients With NSCLC by Whole Genome Sequencing

Fatal Airway Inflammation Induced by Pembrolizumab in a Patient With NSCLC

Loss of P16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated With Worse Outcome and Younger Age in Thymic Carcinomas

Sequential Atezolizumab Achieved Remarkable Efficacy After Local Radiotherapy in a Patient With Lung Adenocarcinoma Refractory to Nivolumab

Adi Gazdar, MD: Physician, Pathologist, Scholar, Collaborator, Friend